BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28130198)

  • 1. Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme.
    Morgenstern J; Baumann P; Brunner C; Hubbuch J
    Int J Pharm; 2017 Mar; 519(1-2):408-417. PubMed ID: 28130198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of PEGylated proteases with varying degree of conjugation in mixtures: An analytical protocol combining protein precipitation and capillary gel electrophoresis.
    Morgenstern J; Busch M; Baumann P; Hubbuch J
    J Chromatogr A; 2016 Sep; 1462():153-64. PubMed ID: 27521256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batch purification of high-purity lysozyme from egg white and characterization of the enzyme modified by PEGylation.
    Silva Freitas Dd; Abrahão-Neto J
    Pharm Biol; 2010 May; 48(5):554-62. PubMed ID: 20645799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biophysical characterization of lysozyme modified by PEGylation.
    Freitas Dda S; Abrahão-Neto J
    Int J Pharm; 2010 Jun; 392(1-2):111-7. PubMed ID: 20307635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of random PEGylation reactions by means of high throughput screening.
    Maiser B; Dismer F; Hubbuch J
    Biotechnol Bioeng; 2014 Jan; 111(1):104-14. PubMed ID: 23939788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
    Müller E; Josic D; Schröder T; Moosmann A
    J Chromatogr A; 2010 Jul; 1217(28):4696-703. PubMed ID: 20570270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adsorption of poly(ethylene glycol)-modified lysozyme to silica.
    Daly SM; Przybycien TM; Tilton RD
    Langmuir; 2005 Feb; 21(4):1328-37. PubMed ID: 15697278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of pegylated proteins.
    Fee CJ; Van Alstine JM
    Methods Biochem Anal; 2011; 54():339-62. PubMed ID: 21954785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of lysozyme phase behavior by additives as function of conformational stability.
    Galm L; Morgenstern J; Hubbuch J
    Int J Pharm; 2015 Oct; 494(1):370-80. PubMed ID: 26302861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential Interactions and the Effect of Protein PEGylation.
    Holm LS; Thulstrup PW; Kasimova MR; van de Weert M
    PLoS One; 2015; 10(7):e0133584. PubMed ID: 26230338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformation of the poly(ethylene glycol) chain in mono-PEGylated lysozyme and mono-PEGylated human growth hormone.
    Pai SS; Hammouda B; Hong K; Pozzo DC; Przybycien TM; Tilton RD
    Bioconjug Chem; 2011 Nov; 22(11):2317-23. PubMed ID: 21950579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform separation and binding site determination of mono-PEGylated lysozyme with pH gradient chromatography.
    Maiser B; Kröner F; Dismer F; Brenner-Weiss G; Hubbuch J
    J Chromatogr A; 2012 Dec; 1268():102-8. PubMed ID: 23146338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and preparative separation of PEGylated lysozyme for the characterization of chromatography media.
    Moosmann A; Christel J; Boettinger H; Mueller E
    J Chromatogr A; 2010 Jan; 1217(2):209-15. PubMed ID: 19963219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG chain length impacts yield of solid-phase protein PEGylation and efficiency of PEGylated protein separation by ion-exchange chromatography: insights of mechanistic models.
    Yoshimoto N; Isakari Y; Itoh D; Yamamoto S
    Biotechnol J; 2013 Jul; 8(7):801-10. PubMed ID: 23788446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of PEGyated Concanavalin A for affinity chromatography with improved stability.
    Wen Z; Niemeyer B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(20):1732-40. PubMed ID: 21571597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of protein A chromatography ligands with polyethylene glycol. I: Effects on IgG adsorption equilibrium, kinetics, and transport.
    Weinberg J; Zhang S; Crews G; Carta G; Przybycien T
    J Chromatogr A; 2018 Apr; 1546():77-88. PubMed ID: 29551236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attachment of degradable poly(ethylene glycol) to proteins has the potential to increase therapeutic efficacy.
    Roberts MJ; Harris JM
    J Pharm Sci; 1998 Nov; 87(11):1440-5. PubMed ID: 9811503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembly PEGylation Retaining Activity (SPRA) Technology via a Host-Guest Interaction Surpassing Conventional PEGylation Methods of Proteins.
    Hirotsu T; Higashi T; Abu Hashim II; Misumi S; Wada K; Motoyama K; Arima H
    Mol Pharm; 2017 Feb; 14(2):368-376. PubMed ID: 28032772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of PEGylated protein using membrane chromatography.
    Yu D; Ghosh R
    J Pharm Sci; 2010 Aug; 99(8):3326-33. PubMed ID: 20186937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of protein phase diagrams by microbatch experiments: exploring the influence of precipitants and pH.
    Baumgartner K; Galm L; Nötzold J; Sigloch H; Morgenstern J; Schleining K; Suhm S; Oelmeier SA; Hubbuch J
    Int J Pharm; 2015 Feb; 479(1):28-40. PubMed ID: 25541147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.